WT1 expression is usually focally positive (in up to 30% of cases) or negative in uterine serous carcinoma 27, and this marker is therefore not routinely applied in the differential diagnosis between grade 3 endometrioid carcinoma and serous carcinoma at this anatomic site. The gene discussed is WT1; the disease is endometrioid adenocarcinoma.